AUDIO from Medialink and NAELA: Protection for ...( NEW YORK March 20 /- The National...),Health
Navigation Links
AUDIO from Medialink and NAELA: Protection for Our Elders
Date:3/20/2008
NEW YORK, March 20 /PRNewswire/ -- The National Academy of Elder Law
Attorneys, or NAELA, is urging Congressional passage of The Elder Justice
Act to help protect seniors. A NAELA survey found that twenty percent of
Americans aged 35 and older had experienced elder abuse -- whether
financial, physical or emotional -- directed at themselves or their
parents.
Listen to this report from NAELA at: http://media.medialink.com/WebNR.aspx?story=34838
Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://mediaseed.tv
03DC08-0034
'/>"/>
| SOURCE Medialink and NAELA Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. AUDIO from Medialink and Kelloggs: A Blissful Way to Recommit to Your Resolution
2. AUDIO from Medialink and the Anxiety Disorders Association of America: Treat It, Dont Repeat It: Break Free from OCD
3. AUDIO from Medialink and Kelloggs: A Healthy Beginning Every Day
4. AUDIO from Medialink and Transitions: Understanding the Dangers of UV Rays
5. AUDIO from Medialink and Pfizer: February is National Heart Month
6. AUDIO from Medialink and Colgate: A Healthy Smile - Not Just a Question for Your Dentist
7. AUDIO from Medialink and AXA Equitable: Timing Retirement Thinking
8. AUDIO From Medialink and the National Association of Margarine Manufacturers: Survey Finds Americans Unaware Some Fats Are Good for Heart Health
9. AUDIO from Medialink and Kelloggs: Ten Delicious Days to Better Digestive Health
10. AUDIO from Medialink and Kellogg: Ten Delicious Days to Better Digestive Health
11. Free Book: Critically Acclaimed Book on Anger Management Now Available in Both Unabridged Audio and Print Form Worldwide
Post Your Comments:
(Date:12/4/2009)... , PEMBROKE, Bermuda, Dec. 4 /PRNewswire-Fi...s, Ltd (NYSE: AWH ) today announced that Scott C...nd Jack Sennott, Executive Vice,President and Chie...t the 2009,Goldman Sachs U.S. Financial Services C...ce Center in New York City on Tuesday, December 8,...
(Date:12/4/2009)..., KANSAS CITY, Mo., Dec. 4 The ... National Association of Free Clinics (NAFC) in Ka...r the sick but also for anyone who is uninsured an... in the health clinic will receive preventive prim...ee previous large free clinic events this fall in ...
(Date:12/4/2009)... , WASHINGTON, Dec. 4 /PRNewswire-USNewswire/ -...m would control health care costs, Leapfrog,s purc...ugh example -- delivering the best quality care in...efficiency. Thirty-four urban, eight children,s an...rog Top Hospitals, based on results from The Leapf...
(Date:12/4/2009)... STANFORD, Calif. A new study shows that muscle ...ability to squeeze shut properly. The work, perfor...patients with conditions such as gastric reflux an...ed to strengthen sphincters, which are the bands o...intestinal tract. Weakness in these areas can caus...
(Date:12/4/2009)... than 15 million Americans are recruited annually ... Alliance for Human Research Protection (AHRP), an.... , Research institutions view payments to v...ot as compensation for potential risks related to ... finds that volunteers have a very different view ...
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Human guinea pigs wary of high-paying medical trials 2[0] Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference[0] Free Health Clinic Event Is Not Just for the Sick[0] The Leapfrog Group Releases Its 2009 Top Hospitals List[0] Muscle cell infusion shown to strengthen sphincters in animals in Stanford study[0] Human guinea pigs wary of high-paying medical trials
...nologies Inc., a,leading developer and manufacture...today announced that the company has entered into ... with LightLab imaging.,Under this multi- year exc... system., (Photo: http://www.newscom.com/cgi-bin...
.... (San Francisco, CA,and Ottawa, Canada), announce...delivered a plenary session presentation on Friday... with JX-594, a Novel Targeted,Multi-Mechanistic O...his abstract was selected for presentation in the,...
...ata Demonstrating Superiority of XIENCE ...KYO, June 2 Abbott (NYSE: ABT ) today,announced ...bai Shonin,(Marketing Authorization License) to Ja...s Eluting Coronary Stent System to,treat coronary ...
...(OTC,Bulletin Board: IAGX) announced today that it...aVie LLC (http://www.monavie.com ) that provides ... Celadrin, a cellular lubricant, is a joint healt...ty.,Celadrin is a unique, scientifically arranged ...
...k II anaerobic,system for the cultivation of anaer... an excellent alternative to the use of anaerobic ...aboratories. The Anoxomat Mark II,automatic jar ev...the way the Anoxomat jar works, I can open it up, ...
..., kept tumors stable for almost 6 months , ...n therapy of gemcitabine, capecitabine and bevaciz...ancreatic cancer, according to a multi-center stud...ated by patients, was able to prevent tumors from ...
Other Medicine News:Health News:Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab Imaging 2Health News:Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference 2Health News:Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 2Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 3Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 4Health News:Abbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 5Health News:Imagenetix Enters into Business Relationship with MonaVie 2Health News:Advanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories 2Health News:Advanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories 3Axsun Technologies Announces Exclusive Cardiac Supply Agreement for Advanced OCT Tunable Lasers with LightLab ImagingJennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International ConferenceAbbott Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in JapanImagenetix Enters into Business Relationship with MonaVieAdvanced Instruments' Anoxomat Mark II Anaerobic System is Excellent Alternative to Anaerobic Chambers, Gas Bags in Clinical Laboratories3-Drug Combo Improves Advanced Pancreatic Cancer Outcomes
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-FirstC...), a leading global specialty pharmaceutical compa...boratories, Inc.-Florida, filed an Abbreviated New...ug Administration seeking approval to market its 8...patent owned by Takeda Pharmaceutical Company Limi...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-FirstCa...that the US Food and Drug Administration (FDA) has... fumarate) Extended Release Tablets as adjunctive ...th Major Depressive Disorder (MDD). SEROQUEL XR is...FDA to treat both major depressive disorder as adj...
(Date:12/3/2009)... , ALISO VIEJO, Calif. and STATE COLLEGE, Pa.,...etics today announced the signing of an agreement ...es using SoftGenetics, NextGENe software for next-... ,, (Logo: http://www.newscom.com/cgi-bin/p...PhD, Ambry,s CSO said, "Our team at Ambry has been...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 1Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 2Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 3Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 4Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 5Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 6Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 7Shire Announces FDA Approval of Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets for the Treatment of ADHD in Children and Adolesc 4939 8Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 1Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 2Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 3HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 1HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 2HerbalScience Research Demonstrates that Optimized Turmeric Extract Inhibits Amyloid Beta Accumulation a Hallmark of Alzheimers Disease 56123 3..., a specialty,biopharmaceutical company focused on...nounced the start of a further phase II clinical s...of cat allergy. The trial builds on,positive resul...monstrated,the potential clinical benefits of the ...In the previous phase II clinical trial, patients ...
...al lozenge) developed to be the first sleep aid s...n patients awaken and have difficulty retu...nscept Pharmaceuticals,Inc., a privately-held spec... it has submitted a New Drug Application (NDA) to ...s lead product candidate, Intermezzo(R),(zolpidem ...
Other Medicine Technology:Circassia Initiates Further Phase II Clinical Study of Toleromune(R) Anti-Allergy Technology 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 2Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 3Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 4Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 5Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings 6Complete brand Blink-N-Clean Lens Drops
Renu Preservative Free Lubricating and Rewetting Drops
Sterile Preserved Saline Solution
Sensitive Eyes Plus Saline Solution
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |